MoneyWorks4Me

Windlas Biotech informs about analyst meet

29 Apr 2024 Evaluate

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Windlas Biotech has informed that the officials of the Company will be attending the meeting with an Investor/Analyst at the Dehradun Plant on Friday, May 03, 2024. Discussions will be based on publicly available information. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..